×

Merit Medical Systems EBITDA 2010-2024 | MMSI

Merit Medical Systems annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Merit Medical Systems EBITDA for the quarter ending December 31, 2024 was $0.070B, a 15.77% increase year-over-year.
  • Merit Medical Systems EBITDA for the twelve months ending December 31, 2024 was $0.277B, a 22.15% increase year-over-year.
  • Merit Medical Systems 2024 annual EBITDA was $0.277B, a 22.15% increase from 2023.
  • Merit Medical Systems 2023 annual EBITDA was $0.227B, a 25.85% increase from 2022.
  • Merit Medical Systems 2022 annual EBITDA was $0.18B, a 14.67% increase from 2021.
Merit Medical Systems Annual EBITDA
(Millions of US $)
2024 $277
2023 $227
2022 $180
2021 $157
2020 $106
2019 $120
2018 $129
2017 $87
2016 $79
2015 $76
2014 $77
2013 $61
2012 $52
2011 $52
2010 $32
2009 $45
Merit Medical Systems Quarterly EBITDA
(Millions of US $)
2024-12-31 $70
2024-09-30 $68
2024-06-30 $74
2024-03-31 $64
2023-12-31 $61
2023-09-30 $62
2023-06-30 $54
2023-03-31 $50
2022-12-31 $54
2022-09-30 $42
2022-06-30 $46
2022-03-31 $38
2021-12-31 $46
2021-09-30 $40
2021-06-30 $33
2021-03-31 $39
2020-12-31 $43
2020-09-30 $27
2020-06-30 $8
2020-03-31 $28
2019-12-31 $23
2019-09-30 $24
2019-06-30 $38
2019-03-31 $35
2018-12-31 $33
2018-09-30 $39
2018-06-30 $33
2018-03-31 $24
2017-12-31 $28
2017-09-30 $15
2017-06-30 $26
2017-03-31 $18
2016-12-31 $25
2016-09-30 $15
2016-06-30 $22
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $22
2015-03-31 $18
2014-12-31 $24
2014-09-30 $21
2014-06-30 $16
2014-03-31 $15
2013-12-31 $20
2013-09-30 $17
2013-06-30 $15
2013-03-31 $10
2012-12-31 $10
2012-09-30 $15
2012-06-30 $14
2012-03-31 $13
2011-12-31 $11
2011-09-30 $11
2011-06-30 $15
2011-03-31 $15
2010-12-31 $10
2010-09-30 $0
2010-06-30 $12
2010-03-31 $10
2009-12-31 $11
2009-09-30 $12
2009-06-30 $12
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.219B $1.357B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $84.343B 23.08
Becton Dickinson (BDX) United States $65.771B 16.47
Cardinal Health (CAH) United States $33.281B 17.82
Labcorp (LH) United States $19.480B 15.97
Straumann Holding AG (SAUHY) Switzerland $19.198B 0.00
Cooper (COO) United States $16.868B 22.37
West Pharmaceutical Services (WST) United States $16.185B 33.17
Align Technology (ALGN) United States $11.630B 22.53
Henry Schein (HSIC) United States $8.505B 14.45
DENTSPLY SIRONA (XRAY) United States $2.973B 8.95
Patterson (PDCO) United States $2.764B 15.94
CONMED (CNMD) United States $1.867B 14.52
STAAR Surgical (STAA) United States $0.870B 0.00
Lifevantage (LFVN) United States $0.183B 20.25
Pro-Dex (PDEX) United States $0.162B 24.67